Prestige Consumer Healthcare Inc. (NYSE: PBH) Stock Competitors & Peer Comparison

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, RPRX has a market cap of 29.6B. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while RPRX trades at $66.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas RPRX's P/E ratio is 12.67. In terms of profitability, PBH's ROE is +0.09%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, PBH is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for PBH.Check RPRX's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while WBA trades at $11.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas WBA's P/E ratio is -1.64. In terms of profitability, PBH's ROE is +0.09%, compared to WBA's ROE of -0.57%. Regarding short-term risk, PBH is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for PBH.Check WBA's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, CORT has a market cap of 8.7B. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while CORT trades at $80.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas CORT's P/E ratio is 229.89. In terms of profitability, PBH's ROE is +0.09%, compared to CORT's ROE of +0.08%. Regarding short-term risk, PBH is less volatile compared to CORT. This indicates lower risk in terms of short-term price fluctuations for PBH.Check CORT's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, KNSA has a market cap of 7.1B. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while KNSA trades at $90.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas KNSA's P/E ratio is 69.77. In terms of profitability, PBH's ROE is +0.09%, compared to KNSA's ROE of +0.17%. Regarding short-term risk, PBH is less volatile compared to KNSA. This indicates lower risk in terms of short-term price fluctuations for PBH.Check KNSA's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, LQDA has a market cap of 3.7B. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while LQDA trades at $41.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas LQDA's P/E ratio is 30.55. In terms of profitability, PBH's ROE is +0.09%, compared to LQDA's ROE of +1.50%. Regarding short-term risk, PBH is less volatile compared to LQDA. This indicates lower risk in terms of short-term price fluctuations for PBH.Check LQDA's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while HROWL trades at $25.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas HROWL's P/E ratio is N/A. In terms of profitability, PBH's ROE is +0.09%, compared to HROWL's ROE of -1.04%. Regarding short-term risk, PBH is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for PBH.Check HROWL's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while HROWM trades at $26.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas HROWM's P/E ratio is N/A. In terms of profitability, PBH's ROE is +0.09%, compared to HROWM's ROE of -1.04%. Regarding short-term risk, PBH is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for PBH.Check HROWM's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, LTGO has a market cap of 811.5M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while LTGO trades at $13.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas LTGO's P/E ratio is -5.35. In terms of profitability, PBH's ROE is +0.09%, compared to LTGO's ROE of N/A. Regarding short-term risk, PBH is less volatile compared to LTGO. This indicates lower risk in terms of short-term price fluctuations for PBH.Check LTGO's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, HELP has a market cap of 545.5M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while HELP trades at $8.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas HELP's P/E ratio is -2.11. In terms of profitability, PBH's ROE is +0.09%, compared to HELP's ROE of -0.71%. Regarding short-term risk, PBH is less volatile compared to HELP. This indicates lower risk in terms of short-term price fluctuations for PBH.Check HELP's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, SVA has a market cap of 464.9M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while SVA trades at $6.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas SVA's P/E ratio is -5.68. In terms of profitability, PBH's ROE is +0.09%, compared to SVA's ROE of -0.01%. Regarding short-term risk, PBH is more volatile compared to SVA. This indicates higher risk in terms of short-term price fluctuations for PBH.Check SVA's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, CUVL has a market cap of 249.9M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while CUVL trades at $4.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas CUVL's P/E ratio is 10.68. In terms of profitability, PBH's ROE is +0.09%, compared to CUVL's ROE of N/A. Regarding short-term risk, PBH is less volatile compared to CUVL. This indicates lower risk in terms of short-term price fluctuations for PBH.Check CUVL's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, HITI has a market cap of 230.9M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while HITI trades at $2.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas HITI's P/E ratio is -9.57. In terms of profitability, PBH's ROE is +0.09%, compared to HITI's ROE of -0.36%. Regarding short-term risk, PBH is less volatile compared to HITI. This indicates lower risk in terms of short-term price fluctuations for PBH.Check HITI's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, CELG-RI has a market cap of 194.1M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while CELG-RI trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas CELG-RI's P/E ratio is N/A. In terms of profitability, PBH's ROE is +0.09%, compared to CELG-RI's ROE of +0.44%. Regarding short-term risk, PBH is more volatile compared to CELG-RI. This indicates higher risk in terms of short-term price fluctuations for PBH.Check CELG-RI's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, ETRA has a market cap of 155.1M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while ETRA trades at $7.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas ETRA's P/E ratio is -2.76. In terms of profitability, PBH's ROE is +0.09%, compared to ETRA's ROE of N/A. Regarding short-term risk, PBH is less volatile compared to ETRA. This indicates lower risk in terms of short-term price fluctuations for PBH.Check ETRA's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, TRXB has a market cap of 114.4M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while TRXB trades at $13.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas TRXB's P/E ratio is -5.56. In terms of profitability, PBH's ROE is +0.09%, compared to TRXB's ROE of N/A. Regarding short-term risk, PBH is less volatile compared to TRXB. This indicates lower risk in terms of short-term price fluctuations for PBH.Check TRXB's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, ATLN has a market cap of 68.6M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while ATLN trades at $0.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas ATLN's P/E ratio is -0.68. In terms of profitability, PBH's ROE is +0.09%, compared to ATLN's ROE of -83.20%. Regarding short-term risk, PBH is less volatile compared to ATLN. This indicates lower risk in terms of short-term price fluctuations for PBH.Check ATLN's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, CTOR has a market cap of 55.2M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while CTOR trades at $0.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas CTOR's P/E ratio is -1.26. In terms of profitability, PBH's ROE is +0.09%, compared to CTOR's ROE of -1.03%. Regarding short-term risk, PBH is less volatile compared to CTOR. This indicates lower risk in terms of short-term price fluctuations for PBH.Check CTOR's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, RTSN has a market cap of 43.6M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while RTSN trades at $11.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas RTSN's P/E ratio is -4.45. In terms of profitability, PBH's ROE is +0.09%, compared to RTSN's ROE of N/A. Regarding short-term risk, PBH is less volatile compared to RTSN. This indicates lower risk in terms of short-term price fluctuations for PBH.Check RTSN's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while RAD trades at $0.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas RAD's P/E ratio is -0.05. In terms of profitability, PBH's ROE is +0.09%, compared to RAD's ROE of +2.76%. Regarding short-term risk, PBH is less volatile compared to RAD. This indicates lower risk in terms of short-term price fluctuations for PBH.Check RAD's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while GLTO trades at $21.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas GLTO's P/E ratio is -1.78. In terms of profitability, PBH's ROE is +0.09%, compared to GLTO's ROE of -0.83%. Regarding short-term risk, PBH is less volatile compared to GLTO. This indicates lower risk in terms of short-term price fluctuations for PBH.Check GLTO's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, COSM has a market cap of 31.1M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while COSM trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas COSM's P/E ratio is -0.42. In terms of profitability, PBH's ROE is +0.09%, compared to COSM's ROE of -1.19%. Regarding short-term risk, PBH is less volatile compared to COSM. This indicates lower risk in terms of short-term price fluctuations for PBH.Check COSM's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, NSRX has a market cap of 27.6M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while NSRX trades at $3.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas NSRX's P/E ratio is -4.44. In terms of profitability, PBH's ROE is +0.09%, compared to NSRX's ROE of -1.59%. Regarding short-term risk, PBH is less volatile compared to NSRX. This indicates lower risk in terms of short-term price fluctuations for PBH.Check NSRX's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, SCYX has a market cap of 24M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while SCYX trades at $3.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas SCYX's P/E ratio is -1.11. In terms of profitability, PBH's ROE is +0.09%, compared to SCYX's ROE of -0.21%. Regarding short-term risk, PBH is less volatile compared to SCYX. This indicates lower risk in terms of short-term price fluctuations for PBH.Check SCYX's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, POM has a market cap of 16.4M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while POM trades at $1.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas POM's P/E ratio is -0.28. In terms of profitability, PBH's ROE is +0.09%, compared to POM's ROE of +0.80%. Regarding short-term risk, PBH is less volatile compared to POM. This indicates lower risk in terms of short-term price fluctuations for PBH.Check POM's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, BFRI has a market cap of 13M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while BFRI trades at $0.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas BFRI's P/E ratio is -1.59. In terms of profitability, PBH's ROE is +0.09%, compared to BFRI's ROE of -1.28%. Regarding short-term risk, PBH is less volatile compared to BFRI. This indicates lower risk in terms of short-term price fluctuations for PBH.Check BFRI's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, CNSY has a market cap of 12.9M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while CNSY trades at $1.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas CNSY's P/E ratio is -0.41. In terms of profitability, PBH's ROE is +0.09%, compared to CNSY's ROE of -3.94%. Regarding short-term risk, PBH is less volatile compared to CNSY. This indicates lower risk in terms of short-term price fluctuations for PBH.Check CNSY's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, AZR has a market cap of 10.4M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while AZR trades at $3.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas AZR's P/E ratio is -0.24. In terms of profitability, PBH's ROE is +0.09%, compared to AZR's ROE of N/A. Regarding short-term risk, PBH is less volatile compared to AZR. This indicates lower risk in terms of short-term price fluctuations for PBH.Check AZR's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while CJJD trades at $1.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas CJJD's P/E ratio is -0.46. In terms of profitability, PBH's ROE is +0.09%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, PBH is less volatile compared to CJJD. This indicates lower risk in terms of short-term price fluctuations for PBH.Check CJJD's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while SSY trades at $1.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas SSY's P/E ratio is -2.86. In terms of profitability, PBH's ROE is +0.09%, compared to SSY's ROE of -0.09%. Regarding short-term risk, PBH is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for PBH.Check SSY's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, SCNX has a market cap of 5.3M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while SCNX trades at $3.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas SCNX's P/E ratio is -1.54. In terms of profitability, PBH's ROE is +0.09%, compared to SCNX's ROE of -0.54%. Regarding short-term risk, PBH is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for PBH.Check SCNX's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, BGMS has a market cap of 5M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while BGMS trades at $0.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas BGMS's P/E ratio is -0.25. In terms of profitability, PBH's ROE is +0.09%, compared to BGMS's ROE of -0.32%. Regarding short-term risk, PBH is more volatile compared to BGMS. This indicates higher risk in terms of short-term price fluctuations for PBH.Check BGMS's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while MDVL trades at $1.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas MDVL's P/E ratio is -0.05. In terms of profitability, PBH's ROE is +0.09%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, PBH is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for PBH.Check MDVL's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, EOCN has a market cap of 2.8M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while EOCN trades at $2.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas EOCN's P/E ratio is -0.19. In terms of profitability, PBH's ROE is +0.09%, compared to EOCN's ROE of N/A. Regarding short-term risk, PBH is less volatile compared to EOCN. This indicates lower risk in terms of short-term price fluctuations for PBH.Check EOCN's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, PAVS has a market cap of 2.7M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while PAVS trades at $3.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas PAVS's P/E ratio is -0.03. In terms of profitability, PBH's ROE is +0.09%, compared to PAVS's ROE of -0.46%. Regarding short-term risk, PBH is less volatile compared to PAVS. This indicates lower risk in terms of short-term price fluctuations for PBH.Check PAVS's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while ATNFW trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas ATNFW's P/E ratio is N/A. In terms of profitability, PBH's ROE is +0.09%, compared to ATNFW's ROE of -2.15%. Regarding short-term risk, PBH is less volatile compared to ATNFW. This indicates lower risk in terms of short-term price fluctuations for PBH.Check ATNFW's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while BGMSP trades at $1.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, PBH's ROE is +0.09%, compared to BGMSP's ROE of -0.32%. Regarding short-term risk, PBH is less volatile compared to BGMSP. This indicates lower risk in terms of short-term price fluctuations for PBH.Check BGMSP's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while AZNH trades at $53.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas AZNH's P/E ratio is 38.35. In terms of profitability, PBH's ROE is +0.09%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, PBH is more volatile compared to AZNH. This indicates higher risk in terms of short-term price fluctuations for PBH.Check AZNH's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, ASBP has a market cap of 842.2K. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while ASBP trades at $7.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas ASBP's P/E ratio is -0.31. In terms of profitability, PBH's ROE is +0.09%, compared to ASBP's ROE of +19.93%. Regarding short-term risk, PBH is less volatile compared to ASBP. This indicates lower risk in terms of short-term price fluctuations for PBH.Check ASBP's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, BFRIW has a market cap of 796.7K. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while BFRIW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas BFRIW's P/E ratio is N/A. In terms of profitability, PBH's ROE is +0.09%, compared to BFRIW's ROE of -1.28%. Regarding short-term risk, PBH is more volatile compared to BFRIW. This indicates higher risk in terms of short-term price fluctuations for PBH.Check BFRIW's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while LFLYW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, PBH's ROE is +0.09%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, PBH is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for PBH.Check LFLYW's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, ASBPW has a market cap of 149.5K. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while ASBPW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas ASBPW's P/E ratio is N/A. In terms of profitability, PBH's ROE is +0.09%, compared to ASBPW's ROE of +19.93%. Regarding short-term risk, PBH is less volatile compared to ASBPW. This indicates lower risk in terms of short-term price fluctuations for PBH.Check ASBPW's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, PRPH has a market cap of 91.1K. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while PRPH trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas PRPH's P/E ratio is N/A. In terms of profitability, PBH's ROE is +0.09%, compared to PRPH's ROE of -13.59%. Regarding short-term risk, PBH is less volatile compared to PRPH. This indicates lower risk in terms of short-term price fluctuations for PBH.Check PRPH's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, OREX has a market cap of 0. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while OREX trades at $0.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas OREX's P/E ratio is -0.14. In terms of profitability, PBH's ROE is +0.09%, compared to OREX's ROE of -0.54%. Regarding short-term risk, PBH is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for PBH.Check OREX's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, ESRX has a market cap of 0. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while ESRX trades at $92.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas ESRX's P/E ratio is 10.69. In terms of profitability, PBH's ROE is +0.09%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, PBH is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for PBH.Check ESRX's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, POZN has a market cap of 0. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while POZN trades at $5.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas POZN's P/E ratio is N/A. In terms of profitability, PBH's ROE is +0.09%, compared to POZN's ROE of +0.61%. Regarding short-term risk, PBH is less volatile compared to POZN. This indicates lower risk in terms of short-term price fluctuations for PBH.Check POZN's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, IPXL has a market cap of 0. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while IPXL trades at $18.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas IPXL's P/E ratio is -10.11. In terms of profitability, PBH's ROE is +0.09%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, PBH is less volatile compared to IPXL. This indicates lower risk in terms of short-term price fluctuations for PBH.Check IPXL's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, SHPG has a market cap of 0. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while SHPG trades at $179.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas SHPG's P/E ratio is 11.35. In terms of profitability, PBH's ROE is +0.09%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, PBH is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for PBH.Check SHPG's competition here

Prestige Consumer Healthcare Inc. (NYSE: PBH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 2.4B. In comparison, CPD has a market cap of 0. Regarding current trading prices, PBH is priced at $49.73 on the NYSE, while CPD trades at $5.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 11.26, whereas CPD's P/E ratio is N/A. In terms of profitability, PBH's ROE is +0.09%, compared to CPD's ROE of N/A. Regarding short-term risk, PBH is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for PBH.Check CPD's competition here